Literature DB >> 3349334

Fate of the ischaemic limb in Buerger's disease.

T Ohta1, S Shionoya.   

Abstract

The clinical course of 328 patients with Buerger's disease (thromboangiitis obliterans: TAO) was followed. Neither ischaemic ulcers nor gangrene occurred in 26 per cent of the patients. Almost all of the ulcers occurred in patients between 20 and 50 years of age, with a peak incidence between 40 and 45 years. The younger the patient at the onset of the disease, the later the first ulcer occurred, and the later the first ulcer occurred, the shorter the period in which ulceration may recur. Recurrent ulcers were observed in 45 per cent of the patients. The progression of symptoms was influenced by smoking, but this was not the only deleterious factor as there were patients with stable TAO unaffected by smoking. In the 30 patients over the age of 60 years, ulceration and gangrene were not observed. In all patients, the progression of symptoms was self-limited and recurrent ulcers occurred less frequently with ageing. The rate of major amputation was low (3.9 per cent) although minor digital amputations were sometimes required. The survival rate of patients with TAO was higher than that of patients with arteriosclerosis obliterans. The aim of treatment in patients with TAO is to make patients abstain from smoking to prevent ulceration and to shorten the period of healing of trophic lesions without major amputation, as ulceration and gangrene in T AO are limited to the most distal part of the limbs, and seems to have healing potential.

Entities:  

Mesh:

Year:  1988        PMID: 3349334     DOI: 10.1002/bjs.1800750324

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  HLA antigens in Burger's disease.

Authors:  J Zervas; G Vayopoulos; K Konstantopoulos; C Zervas; C Liapis; P Kaklamanis; M Sechas
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

Review 2.  Thromboangiitis obliterans. An update on Buerger's disease.

Authors:  A Szuba; J P Cooke
Journal:  West J Med       Date:  1998-04

3.  The Clinical Course of Buerger's Disease.

Authors:  Takashi Ohta; Hiroyuki Ishibashi; Ikuo Sugimoto; Hirohide Iwata; Jun Kawanishi; Tetsuya Yamada; Masao Tadakoshi; Noriyuki Hida
Journal:  Ann Vasc Dis       Date:  2008-10-24

Review 4.  Current status of patients with buerger disease in Japan.

Authors:  Noriyuki Hida; Takashi Ohta
Journal:  Ann Vasc Dis       Date:  2013-08-12

5.  Vascular Function and Intima-media Thickness of a Leg Artery in Peripheral Artery Disease: A Comparison of Buerger Disease and Atherosclerotic Peripheral Artery Disease.

Authors:  Akimichi Iwamoto; Masato Kajikawa; Tatsuya Maruhashi; Yumiko Iwamoto; Nozomu Oda; Shinji Kishimoto; Shogo Matsui; Yasuki Kihara; Kazuaki Chayama; Chikara Goto; Kensuke Noma; Yoshiki Aibara; Ayumu Nakashima; Yukihito Higashi
Journal:  J Atheroscler Thromb       Date:  2016-05-09       Impact factor: 4.928

Review 6.  Buerger's Disease May be a Chronic Rickettsial Infection with Superimposed Thrombosis: Literature Review and Efficacy of Doxycycline in Three Patients.

Authors:  Moon-Hyun Chung; Jin-Soo Lee; Jae-Seung Kang
Journal:  Infect Chemother       Date:  2022-03

7.  The Association of HLA-A, B and DRB1 with Buerger's Disease.

Authors:  Abbas Shapouri-Moghaddam; Mojgan Mohammadi; Hamid Reza Rahimi; Habibolah Esmaeili; Mahmoud Mahmoudi; Mohammad-Hadi Saeed Modaghegh; Jalil Tavakol Afshari
Journal:  Rep Biochem Mol Biol       Date:  2019-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.